Skip to main content
SpringerLink
Log in

Measurement of health-related QOL in diabetes mellitus

  • Review Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

A number of health-related QOL (HR-QOL) measures specifically designed for people with diabetes mellitus have appeared in the literature. This article provides a selective review of 12 measures that address this important construct. For each included study, a description of the measure and its development phase is provided, followed by discussion of sampling, reliability, validity and appropriateness for selected populations. Measures designed to investigate broad and specific conceptualisations of diabetes-specific QOL are included.

For research in which a broad conceptualisation of diabetes-specific QOL is appropriate, the following measures are recommended: Diabetes-39, Diabetes Care Profile (DCP), Diabetes Impact Management Scales (DIMS), Diabetes Quality of Life (DQOL) and the Diabetes-Specific Quality of Life Scale (DSQOLS). For investigation of one or more specific aspects of diabetes-specific QOL, other measures may also be appropriate: single-scale questionnaires such as the Appraisal of Diabetes Scale (ADS) [stressful impact], Audit of Diabetes-Dependent Quality of Life (ADDQoL) [life without diabetes] and the Problem Areas in Diabetes scale (PAID) [diabetes-related distress]; the Diabetes Health Profile (DHP) which focuses on diabetes-related distress, activity and eating behaviour; the Questionnaire on Stress in Patients with Diabetes-Revised (QSDR) which has a primary focus on diabetes-related distress; and the Well-Being Enquiry for Diabetics (WED) which is primarily concerned with the perceptions of patients with diabetes in relation to mental health. Researchers selecting a diabetes-specific QOL measure should also carefully consider the conceptual underpinnings of the available instruments, as there is little uniformity in the definition and conceptualisation of HR-QOL.

Based upon participants involved in questionnaire development and validation studies, those questionnaires that appear to be most appropriate for use with a variety of patient populations include the Diabetes-39, DIMS, Diabetes Quality of Life Clinical Trial Questionnaire — Revised (DQLCTQ-R), PAID and the QSD-R. The DCP and DHP appear to be especially relevant measures of HR-QOL for patients with type 2 diabetes, while the DQOL, DSQOLS and WED have clear emphases on concerns of individuals with type 1 diabetes. The length of the DQLCTQ-R may raise concerns about its use among some populations (e.g. older adults).

Recommendations for future research include: (i) increasing the diversity of samples used to develop and evaluate existing and new measures in terms of race/ethnicity, age and gender; (ii) examination of the causal relationship between diabetes self-management and QOL using longitudinal designs; (iii) increasing emphasis on the positive aspects of successful chronic illness self-management; and (iv) use of HR-QOL measures to inform empowering relationships between physicians and patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III

Similar content being viewed by others

References

  1. Barr IT. The outcomes movement and health status measures. J Allied Health 1995; 24: 13–28

    PubMed  CAS  Google Scholar 

  2. Bowling A. Measuring health: a review of quality of life measurement scales. 2nd ed. Bristol (PA): Open University Press, 1997

    Google Scholar 

  3. Schipper H, Clinch J, Olweny CLM. Quality of life studies: definitions and conceptual issues. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia (PA): Lippincott-Raven, 1996: 11–24

    Google Scholar 

  4. Shumaker SA, Naughton MI. The international assessment of health-related quality of life: a theoretical perspective. In: Shumaker SA, Berzon RA, editors. The international assessment of health-related quality of life: theory translation, measurement and analysis. Oxford: Rapid Communications, 1995: 3–10

    Google Scholar 

  5. Spilker B. Introduction. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia (PA): Lippincott-Raven, 1996: 1–11

    Google Scholar 

  6. Jacobson AM, de Groot M, Samson J. Quality of life research in patients with diabetes mellitus. In: Dimsdale JE, Baum A, editors. Quality of life in behavioral medicine research. Hillsdale (NJ): Lawrence Erlbaum Associates, 1995: 241–62

    Google Scholar 

  7. Anderson RM, Fitzgerald IT, Wisdom K, et al. A comparison of global versus disease specific quality-of-life measures in patients with NIDDM. Diabetes Care 1997; 20: 299–305

    Article  PubMed  CAS  Google Scholar 

  8. Glasgow, RE. Compliance to diabetes regimens: conceptualization, complexity, and determinants. In: Cramer JA, Spilker B, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991: 209–24

    Google Scholar 

  9. Cox DJ, Gonder-Frederick L. Major developments in behavioral diabetes research. J Consult Clin Psychol 1992; 60 (4): 628–38

    Article  PubMed  CAS  Google Scholar 

  10. Goodall TA, Halford WK. Self-management of diabetes mellitus: a critical review. Health Psychol 1991; 10 (1): 1–8

    Article  PubMed  CAS  Google Scholar 

  11. Spilker B. Quality of life assessments in clinical trials. New York: Raven Press, 1990

    Google Scholar 

  12. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. New York: Oxford University Press, 1996

    Google Scholar 

  13. Bradley C. Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and measurement. Chur, Harwood Academic Publishers, 1994

    Google Scholar 

  14. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297–334

    Article  Google Scholar 

  15. Nunnaly J. Psychometric theory. New York: McGraw-Hill, 1978

    Google Scholar 

  16. Singleton RA, Straits BC. Approaches to social research, third edition. New York: Oxford University Press, 1999

    Google Scholar 

  17. Carey MP, Jorgensen RS, Weinstock RS, et al. Reliability and validity of the Appraisal of Diabetes Scale. J Behav Med 1991; 14: 43–51

    Article  PubMed  CAS  Google Scholar 

  18. Bradley C, Todd C, Gorton T, et al. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999; 8: 79–91

    Article  PubMed  CAS  Google Scholar 

  19. Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev 2002; 18: S64–9

    Article  PubMed  Google Scholar 

  20. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial. BMJ 2002; 325: 746

    Article  Google Scholar 

  21. Boyer JG, Earp JAL. The development of an instrument for assessing the quality of life of people with diabetes: Diabetes 39. Med Care 1997; 35: 440–53

    Article  PubMed  CAS  Google Scholar 

  22. Fitzgerald IT, Gruppen LD, Anderson RM, et al. The influence of treatment modality and ethnicity on attitudes in Type 2 diabetes. Diabetes Care 2000; 23: 313–8

    Article  PubMed  CAS  Google Scholar 

  23. Meadows K, Steen N, McColl E, et al. The Diabetes Health Profile (DHP): a new instrument for assessing the psychosocial profile of insulin requiring patients: development and psychometric evaluation. Qual Life Res 1996; 5: 242–54

    Article  PubMed  CAS  Google Scholar 

  24. Goddijn P, Bilo H, Meadows K, et al. The validity and reliability of the Diabetes Health Profile (DHP) in NIDDM patients referred for insulin therapy. Qual Life Res 1996; 5: 433–42

    Article  PubMed  CAS  Google Scholar 

  25. Meadows K, Abrams C, Sandbaek A. Adaptation of the Diabetes Health Profile (DHP-1) for use with patients with type 2 diabetes mellitus: psychometric evaluation and cross-cultural comparison. Diabet Med 2000; 17: 572–80

    Article  PubMed  CAS  Google Scholar 

  26. Hammond GS, Aoki TT. Measurement of health status in diabetic patients: diabetes impact measurement scales. Diabetes Care 1992; 15: 469–77

    Article  PubMed  CAS  Google Scholar 

  27. DCCT Research Group. Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care 1988; 11: 725–32

    Article  Google Scholar 

  28. Jacobson AM, Diabetes Control and Complications Trial Research Group. The diabetes quality of life measure. In: Bradley C, editor. Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and management. Clint Harwood Academic Publishers, 1996: 65–87

    Google Scholar 

  29. Jacobson AM, De Groot M, Samson, et al. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994; 17: 267–74

    Article  PubMed  CAS  Google Scholar 

  30. Jacobson AM, De Groot M, Samson J. Quality of life research in patients with diabetes mellitus. In: Dimsdale JE, Baum A, editors. Quality of life in behavioral medicine research. Hillsdale (NJ): Lawrence Erlbaum Associates, 1995: 241–62

    Google Scholar 

  31. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on quality-of-life outcomes in the Diabetes Control and Complications Trial. Diabetes Care 1996; 19: 195–203

    Article  Google Scholar 

  32. Shen W, Kotsanos JG, Huster WJ. Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire. Med Care 1999; 37: AS45–66

    Article  PubMed  CAS  Google Scholar 

  33. Bott U, Muhlhauser I, Overmann H, et al. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetes Care 1998; 21: 757–69

    Article  PubMed  CAS  Google Scholar 

  34. Bott U, Ebrahim S, Hirschberger S, et al. Effect of rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with type 1 diabetes. Diabet Med 2003, 20: 626–34

    Article  PubMed  CAS  Google Scholar 

  35. Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care 1995; 18: 754–60

    Article  PubMed  CAS  Google Scholar 

  36. Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale: an evaluation of its clinical utility. Diabetes Care 1997; 20: 760–6

    Article  PubMed  CAS  Google Scholar 

  37. Snoek FJ, Pouwer F, Welch GW, et al. Diabetes-related emotional distress in Dutch and US diabetic patients. Diabetes Care 2000; 23: 1305–9

    Article  PubMed  CAS  Google Scholar 

  38. Welch G, Weinger K, Anderson B, et al. Responsiveness of the problem areas in diabetes (PAID) questionnaire. Diabet Med 2003; 20: 69–72

    Article  PubMed  CAS  Google Scholar 

  39. Herschbach P, Duran G, Waadt S, et al. Psychometric properties of the questionnaire on stress in patients with diabetes-revised (QSD-R). Health Psychol 1997; 16: 171–4

    Article  PubMed  CAS  Google Scholar 

  40. Mannucci E, Ricca V, Bardini G, et al. Well-being enquiry for diabetics: a new measure of diabetes-related quality of life. Diabetes Nutr Metab 1996; 9: 89–102

    Google Scholar 

  41. Fitzgerald IT, Davis WK, Connell CM, et al. Development and validation of the diabetes care profile. Eval Health Prof 1996; 19: 208–30

    Article  PubMed  CAS  Google Scholar 

  42. Anderson RM, Fitzgerald IT, Wisdom, et al. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 1997; 20: 299–305

    Article  PubMed  CAS  Google Scholar 

  43. Ingersoll GM, Marrero DG. A modified quality of life measure for youths: psychometric properties. Diabetes Educ 1991; 17: 114–8

    Article  PubMed  CAS  Google Scholar 

  44. Cheng AY, Tsui EY, Hanley AJG. Cultural adaptation of the Diabetes Quality-of-Life measure for Chinese patients. Diabetes Care 1999; 22: 1216–7

    Article  PubMed  CAS  Google Scholar 

  45. Polonsky WH. Understanding and assessing diabetes-specific quality of life. Diabetes Educ 2000; 13: 36–41

    Google Scholar 

  46. Watkins KW, Connell CM, Fitzgerald IT, et al. Effect of adults’ self-regulation of diabetes on quality-of-life outcomes. Diabetes Care 2000; 23: 1511–5

    Article  PubMed  CAS  Google Scholar 

  47. Boyle JP, Honeycutt AA, Narayan KMV, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care 2001; 24: 1936–40

    Article  PubMed  CAS  Google Scholar 

  48. Watkins KW, Connell CM. Quality of life among older men with diabetes. In: Lunenfeld B, Gooren L, editors. Textbook of men’s health. London: Parthenon Publishing, 2002: 197–206

    Google Scholar 

  49. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999; 15: 205–18

    Article  PubMed  CAS  Google Scholar 

  50. Funnell MM, Anderson RM, Arnold MS, et al. Empowerment: an idea whose time has come in diabetes education. Diabetes Educ 1991; 17: 37–41

    Article  PubMed  CAS  Google Scholar 

  51. Gonder-Frederick LA, Cox DJ, Ritterband LM. Diabetes and behavioral medicine: the second decade. J Consult Clin Psychol 2002; 70: 611–25

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.

The authors wish to thank Ibouratou Mama-Yari Ogoussan for her assistance in the preparation of this manuscript.

Author information

Authors and Affiliations

  1. Department of Health Promotion, Education, and Behavior, the Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, 29208, USA

    Ken Watkins

  2. Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA

    Cathleen M. Connell

Authors
  1. Ken Watkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cathleen M. Connell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ken Watkins.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watkins, K., Connell, C.M. Measurement of health-related QOL in diabetes mellitus. Pharmacoeconomics 22, 1109–1126 (2004). https://doi.org/10.2165/00019053-200422170-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200422170-00002

Keywords

Search

Navigation